This joint resolution seeks to prohibit the licensing of specific defense articles and services to Israel, including 5,000 Small Diameter Bomb Weapon Systems. The bill directly affects the proposed arms sales notification submitted to Congress on March 12, 2026, under the Arms Export Control Act. By passing this resolution, Congress would exercise its authority to disapprove the licensing of these particular defense items. The measure is currently referred to the Committee on Foreign Relations for consideration.
This resolution recognizes the Islamic holy month of Ramadan and extends well wishes to Muslims in the United States and globally for Eid al-Fitr. It formally acknowledges the significance of Ramadan as a period of fasting, spiritual renewal, and reflection for over 2 billion Muslims worldwide. The document highlights the contributions of American Muslims to society, including their roles in the military, government, and various professional fields. This is a symbolic gesture of respect and solidarity rather than a law that changes policy or requires funding.
This resolution supports designating March 21, 2026, as National Women in Agriculture Day to recognize the contributions of women in the agricultural sector. It highlights that over 1.2 million women in the U.S. are agricultural producers, representing more than one-third of all producers, and notes their significant economic impact through farm sales and roles in research, education, and agribusiness. The measure encourages citizens to acknowledge and celebrate women working in agriculture during National Ag Week, aligning with the 2026 International Year of the Woman Farmer.
This bill, known as the Social Determinants for Moms Act, requires the Secretary of Health and Human Services to create a task force aimed at reducing preventable maternal deaths and health disparities in the United States. The task force would include federal agency leaders, community organization representatives, and maternity care providers to develop coordinated strategies addressing both medical and non-medical factors like housing, nutrition, and access to care. Additionally, the bill authorizes $100 million over five years to provide grants to community organizations working in areas with high maternal mortality rates and poverty, focusing on social determinants such as transportation, employment, and environmental conditions. The task force must submit reports to Congress every two years outlining its progress and recommendations for future funding and actions.
This bill establishes a federal task force to address maternal health disparities by coordinating efforts across multiple government agencies and community stakeholders to reduce preventable maternal deaths and serious health complications. The task force will include representatives from various departments such as Health and Human Services, Housing and Urban Development, and Transportation, along with community leaders, patients, and healthcare providers focused on maternal health. Additionally, the bill authorizes $100 million over five years to provide grants to community organizations for addressing social determinants of maternal health including housing, transportation, nutrition, employment, and environmental conditions. These grants prioritize areas with high rates of maternal mortality and poverty, and recipients must submit annual reports on their activities and outcomes. The legislation defines key terms such as maternal mortality and social determinants of maternal health to guide implementation and reporting requirements.
This bill, titled the Women's Heart Health Expansion Act of 2026, extends funding and authority for the WISEWOMAN program, which provides preventive health services to women. It authorizes $250 million over five years (2027-2031) for the Centers for Disease Control and Prevention to award supplemental grants for blood pressure, cholesterol, obesity, and diabetes screenings, along with health education and medical referrals. The program would be administered by existing WISEWOMAN grantees or other healthcare entities serving women eligible under current guidelines or identified as high-risk. Additionally, the bill requires a Government Accountability Office study by September 2027 to evaluate the program's reach, access barriers, and cost-effectiveness in improving cardiovascular health outcomes.
S 3812, the WORK to Save Lives Act, requires the Occupational Safety and Health Administration (OSHA) to issue guidance for most private employers on acquiring opioid overdose reversal medication and training employees annually, while mandating that all federal agencies (including the Veterans Health Administration) must acquire such medication and provide annual employee training. The bill directly affects federal agencies as mandatory participants and private employers (excluding the U.S. Postal Service) as recipients of non-mandatory guidance. Key provisions include a 270-day deadline for OSHA to issue these rules after the bill’s enactment. The law aims to improve workplace safety by making overdose reversal tools more accessible without imposing direct penalties on private businesses.
The Family Vaccine Protection Act establishes formal procedures for the Advisory Committee on Immunization Practices (ACIP) within the Public Health Service Act. It requires the CDC Director to adopt ACIP vaccine recommendations unless they lack scientific support, in which case the Director must publish the rationale and notify Congress within 48 hours. The bill specifies the committee's composition, including required expertise for members and ex-officio members from key health agencies like the FDA and CMS. These provisions affect vaccine recommendations that determine coverage for health insurance plans and the Vaccines for Children Program, ensuring all recommendations are based on peer-reviewed scientific evidence.
S 2903, the Safe Step Act, requires health insurance plans and employers offering health coverage to establish a clear, timely process for patients or doctors to request exceptions when step therapy protocols (where insurers require trying cheaper drugs first) would harm a patient. It mandates approval for exceptions if prior drugs failed, delay would cause severe harm, a drug is unsafe, or a patient is stable on their current medication. Plans must respond to requests within 72 hours (or 24 hours in emergencies) and cover the requested drug without extra cost-sharing. The bill also requires annual reports to the government on exception requests, approvals, denials, and trends by medical condition or specialty. This directly affects patients on health plans with step therapy, their doctors, and the insurers managing those plans.
This bill amends federal education funding rules to prioritize civics and American history education in K-12 schools. It changes eligibility criteria for certain grants under the Elementary and Secondary Education Act by requiring programs to: (1) improve teaching of American history, civics, or government; (2) focus on underserved students and demonstrate innovation; (3) include hands-on civic activities; and (4) teach the Constitution and Bill of Rights. The changes directly affect schools applying for these federal grants by setting new standards for funding approval. The bill modifies existing law without creating new programs or funding streams.
This bill directs the U.S. Department of Health and Human Services to fund research on early detection and treatment of uterine fibroids (non-cancerous uterine tumors) and to award grants to states. The grants will support state programs that increase early detection through screening (like advanced imaging), patient navigation services, public education campaigns, and implementing research-backed strategies. It also requires additional research on disparities in pain management during fibroid surgery and conditions like Asherman’s Syndrome. States receiving grants must report on program outcomes and research findings to Congress every two years. The bill directly affects healthcare systems, providers, and patients - particularly those facing disparities in gynecological care - by expanding access to early detection services.
This bill (S 1677, Ensuring Lasting Smiles Act) requires health insurance plans to cover medically necessary treatments for congenital anomalies or birth defects affecting the eyes, ears, teeth, mouth, or jaw. It mandates coverage for reconstructive services, dental/orthodontic care, and related treatments during the course of medical treatment, while excluding purely cosmetic procedures not medically necessary. Plans may apply cost-sharing requirements similar to those for other medical services but must provide notice about these coverage requirements to participants by January 1, 2026. The bill also directs a study on provider network adequacy and cost impacts related to these coverage requirements, to be completed by December 2027.
